US20060249419A1 - Container for Medicament Powder - Google Patents

Container for Medicament Powder Download PDF

Info

Publication number
US20060249419A1
US20060249419A1 US11/427,370 US42737006A US2006249419A1 US 20060249419 A1 US20060249419 A1 US 20060249419A1 US 42737006 A US42737006 A US 42737006A US 2006249419 A1 US2006249419 A1 US 2006249419A1
Authority
US
United States
Prior art keywords
package
container
moisture
material
medicament
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US11/427,370
Inventor
Anthony Taylor
Michael Golden
Original Assignee
Taylor Anthony J
Golden Michael H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
Priority to GB0015043A priority Critical patent/GB0015043D0/en
Priority to GB0015043.3 priority
Priority to PCT/EP2001/006303 priority patent/WO2001098174A1/en
Priority to US10/276,932 priority patent/US7828150B2/en
Application filed by Taylor Anthony J, Golden Michael H filed Critical Taylor Anthony J
Priority to US11/427,370 priority patent/US20060249419A1/en
Publication of US20060249419A1 publication Critical patent/US20060249419A1/en
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9894007&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=US20060249419(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application status is Abandoned legal-status Critical

Links

Images

Classifications

    • BPERFORMING OPERATIONS; TRANSPORTING
    • B65CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65DCONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D81/00Containers, packaging elements, or packages, for contents presenting particular transport or storage problems, or adapted to be used for non-packaging purposes after removal of contents
    • B65D81/24Adaptations for preventing deterioration or decay of contents; Applications to the container or packaging material of food preservatives, fungicides, pesticides or animal repellants
    • B65D81/26Adaptations for preventing deterioration or decay of contents; Applications to the container or packaging material of food preservatives, fungicides, pesticides or animal repellants with provision for draining away, or absorbing, or removing by ventilation, fluids, e.g. exuded by contents; Applications of corrosion inhibitors or desiccators
    • B65D81/266Adaptations for preventing deterioration or decay of contents; Applications to the container or packaging material of food preservatives, fungicides, pesticides or animal repellants with provision for draining away, or absorbing, or removing by ventilation, fluids, e.g. exuded by contents; Applications of corrosion inhibitors or desiccators for absorbing gases, e.g. oxygen absorbers or desiccants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00Inhalators
    • A61M15/0028Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
    • A61M15/003Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using capsules, e.g. to be perforated or broken-up
    • A61M15/0043Non-destructive separation of the package, e.g. peeling
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00Inhalators
    • A61M15/0028Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
    • A61M15/0045Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using multiple prepacked dosages on a same carrier, e.g. blisters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00Inhalators
    • A61M15/0028Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
    • A61M15/0045Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using multiple prepacked dosages on a same carrier, e.g. blisters
    • A61M15/0046Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using multiple prepacked dosages on a same carrier, e.g. blisters characterized by the type of carrier
    • A61M15/0051Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using multiple prepacked dosages on a same carrier, e.g. blisters characterized by the type of carrier the dosages being arranged on a tape, e.g. strips
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00Inhalators
    • A61M15/0028Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
    • A61M15/0045Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using multiple prepacked dosages on a same carrier, e.g. blisters
    • A61M15/0053Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using multiple prepacked dosages on a same carrier, e.g. blisters characterized by the type or way of disposal
    • A61M15/0055Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using multiple prepacked dosages on a same carrier, e.g. blisters characterized by the type or way of disposal the used dosages being coiled
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00Inhalators
    • A61M15/0065Inhalators with dosage or measuring devices
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00Special media to be introduced, removed or treated
    • A61M2202/06Solids
    • A61M2202/062Desiccants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00Special media to be introduced, removed or treated
    • A61M2202/06Solids
    • A61M2202/064Powder
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2209/00Ancillary equipment
    • A61M2209/06Packaging for specific medical equipment

Abstract

There is provided a container for a medicament powder formed from a material comprising a desiccant. In one embodiment the container is a medicament dispenser comprising a body defining a reservoir for medicament in powder form, and an outlet in communication with said reservoir. In another embodiment the container is a medicament dispenser comprising a body defining a chamber for receipt of a medicament carrier, and an outlet in communication with said chamber. Methods of controlling moisture flow are also described.

Description

    TECHNICAL FIELD
  • The present invention relates to containers and dispensers for medicament powders. In particular, the invention relates to dry powder inhalation dispensers and components thereof which substantially alleviate or reduce moisture build-up therein. The invention also relates to a method for reducing moisture ingress inside a dry powder inhaler.
  • BACKGROUND TO THE INVENTION
  • Medicaments for treating respiratory disorders are frequently administered as dry powder formulations through the mouth and nose. Dry powder medicament dispensers, such as inhalers, are used in the administration of these drugs, inhalation by the patient resulting in uptake of a specified dosage of medicament through the nose or mouth. The drug may be stored as a dry powder within a reservoir in the body of the inhaler, a metering chamber being utilised to administer a specified dose of medicament. Alternatively, more sophisticated medicament dispensers employ medicament carriers, such as individual capsules or blister packs/strips containing defined doses of powdered drug.
  • Patients often rely on medication delivered by dry powder inhalers for rapid treatment of respiratory disorders that are debilitating and in some cases life threatening. It is, therefore, essential that the prescribed dose of drug is delivered accurately and consistently to meet the patient's needs and comply with the requirements of regulatory authorities.
  • A problem which can occur in the storage and product lifetime of an inhaler is ingress of moisture into the medicament powder. A build-up of moisture can prevent the administration of an effective dose of medicament by causing an increase in particle size and/or adherence of hygroscopic particles to the walls of the carrier or device, thereby leading to reduced uptake via inhalation by the patient. In extreme cases, depending upon the chemical nature of the medicament, moisture build-up may lead to degradation of the drug.
  • Another problem can be microbial contamination, which is often assisted by the undesirable presence of excess moisture.
  • The Applicants have found that the inclusion of a desiccant in the body of the inhaler or the walls of the medicament carrier can significantly improve the aforementioned problems. Furthermore, storage of the inhaler or medicament carrier within a sealed package incorporating a desiccant, can markedly reduce moisture ingress.
  • The Applicants has also found that the aforementioned problems can be ameliorated by controlling the ingress of moisture to, or egress of moisture from, the medicament container. Control may be achieved by either suitable choice of container materials or by enclosure of the container or a dispenser including the container in a suitable package. The control need not absolutely prevent moisture transfer. Indeed, the Applicants have found that under certain conditions a limited degree of moisture transfer can be desirable.
  • WO 99/32180 teaches the inclusion of moisture permeable chambers containing desiccants within a blister pack. U.S. Pat. No. 5,740,793 discloses the inclusion of a desiccant cartridge within an inhaler or the medicament carrier cassette. U.S. Pat. No. 5,394,868 describes a chamber within a powder inhaler for holding a desiccating substance. The use of desiccant filters within medicament dispensers is described in U.S. Pat. Nos. 5,687,746 and 5,775,320, and PCT patent application no. WO 89/01348.
  • SUMMARY OF INVENTION
  • According to the present invention, there is provided a container for a medicament powder formed from a material comprising a desiccant.
  • In one aspect, the container is suitable for containing a measured dose of medicament. Packs in blister pack form for the containment of a unit dose medicaments are envisaged, as are packs containing multiple unit dose blisters arranged sequentially or otherwise, such as in series form. A particular multi-unit dose arrangement comprises an elongate strip having multiple blisters arranged in series thereon.
  • In another aspect, the container is a reservoir for dry powder medicament. Metering means are provided to enable metering of dose from the reservoir and transport of that dose to a delivery position.
  • In one aspect, the container is a medicament dispenser comprising a body defining a reservoir for medicament in powder form, and an outlet in communication with said reservoir for release of the medicament. In one aspect, the device is an inhaler and the outlet is one through which a user can inhale.
  • In another aspect, the container is in the form of a reloadable cartridge comprising a medicament pack (e.g. in multi-unit dose blister form or reservoir form). The cartridge is shaped and sized for receipt by a medicament delivery device (e.g. an inhaler device).
  • In another aspect, the container is a medicament dispenser comprising a body defining a chamber for receipt of a medicament carrier, and an outlet in communication with said chamber for release of the medicament. In one aspect, the device is an inhaler and the outlet is one through which the user can inhale.
  • In yet another aspect, the body consists of the material comprising the desiccant.
  • In one aspect, the body comprises the material comprising the desiccant.
  • In another aspect, the material comprising the desiccant coats the body e.g. part or whole of the inside of the body.
  • In yet another aspect, the material comprising the desiccant is impregnated throughout the body.
  • In one aspect, the material comprising the desiccant lines the body (e.g. the interior of the body which contacts the medicament powder in use).
  • Optionally the desiccant comprising material may be located around a seal for sealing the reservoir or medicament carrier optionally the seal (e.g. in the form of a sealing ring) may itself comprise or consist of a desiccant.
  • In another aspect, the container is a medicament carrier.
  • In yet another aspect, the medicament carrier is a capsule comprising a wall enclosing the medicament.
  • In one aspect, the medicament carrier is a blister pack comprising a base sheet and a lid.
  • In another aspect, the medicament carrier comprises a material comprising a desiccant.
  • In yet another aspect, the material comprising the desiccant coats the wall, or the base sheet, or the lid of the medicament carrier.
  • In one aspect, the material comprising the desiccant impregnates the wall, or base sheet, or lid of the medicament carrier.
  • In another aspect, the material comprising the desiccant lines the wall, or base sheet, or lid of the medicament carrier.
  • In another aspect, the material comprising the desiccant is moulded into the wall, or base sheet, or lid of the medicament carrier.
  • In yet another aspect, a well containing desiccant surrounds individual pockets in the blister packs.
  • In one aspect, the blister pack comprises a laminate comprising a desiccant. Suitably, the laminate comprises material selected from the group consisting of metal foil, organic polymeric material and paper. Suitable metal foils include aluminium or tin foil having a thickness of from 5 to 100 μm, preferably from 10 to 50 μm, such as 20 to 30 μm. Suitable organic polymeric materials include polyethylene, polypropylene, polyvinyl chloride and polyethylene terephthalate.
  • Suitably, the base sheet and lid comprise different materials.
  • In another aspect, the material comprising the desiccant is an organic polymeric plastic having particular characteristics e.g. a thermoplastic.
  • In yet another aspect, the organic polymeric plastic is a polyamide.
  • Preferably the desiccant is selected from the group consisting of silica gel, zeolite, alumina, bauxite, anhydrous calcium sulphate, activated bentonite clay, water-absorbing clay, molecular sieve and any mixtures thereof.
  • In one aspect, the container additionally comprises a medicament in dry powder form. Suitably, the medicament is suitable for the treatment of respiratory disorders. Preferably, the medicament is salmeterol xinafoate, fluticasone propionate or a combination thereof.
  • In another aspect of the present invention there is provided a method of reducing water ingress into a medicament powder comprising using a container for a medicament powder according to any of the preceding claims.
  • In another aspect of the present invention there is provided a package for storage of a container for a medicament powder formed from a material capable of controlling the ingress of moisture thereto or egress or moisture therefrom.
  • In one aspect, the material is impermeable to moisture.
  • In another aspect, the material controls the ingress or egress of moisture such that the ambient moisture content within the package is essentially constant, such as varying by no more than ±20%, preferably by less than ±10%. Ambient moisture content may for example be measured by Relative Humidity within the package. The preferred absolute level of moisture content will vary from medicament to medicament but may be readily determined through laboratory testing.
  • In another aspect, the material enables moisture transfer in one way only i.e. ingress only or egress only.
  • In another aspect, the material enables moisture transfer to either a set minimum/maximum moisture content within the package or within a set minimum / maximum moisture transfer rate.
  • In another aspect, the material is also capable of controlling the flow of other gaseous or vapour form species. Tyvek (trade name) is a suitable material.
  • In one aspect, the package is wrappable and sealable around the container to form an enclosed volume in which the container is disposed, the package being impermeable to water vapour, thereby substantially reducing ingress of water vapour and particulate matter into said enclosed volume.
  • In another aspect, the package additionally comprises a desiccant within the enclosed volume.
  • Preferably the desiccant is selected from the group consisting of silica gel, zeolite, alumina, bauxite, anhydrous calcium sulphate, activated bentonite clay, water-absorbing clay, molecular sieve and any mixtures thereof.
  • In one aspect the package includes at least one heat sealable layer and at least one layer of a metal foil.
  • In another aspect, the metal comprising said metal foil is selected from the group consisting of aluminium, tin, iron, zinc and magnesium.
  • In yet another aspect, the package includes protective layers located on the outside of the package.
  • In one aspect, the protective layer comprises a polyester film and the heat sealable layer comprises an ionomer film.
  • In another aspect of the present invention there is provided a method of storing a container for a medicament powder comprising providing a packaging material which is capable of controlling the flow of water vapour; filling a container with a medicament powder; wrapping said container with said package material to form an enclosed volume in which said container is disposed therein; and sealing the package.
  • In yet another aspect, the method additionally comprises providing a desiccant within the enclosed volume.
  • In one aspect, the sealing comprises heat sealing said packaging material. In other aspects, the seal is formed by ultrasonic welding, heat stamping, adhesive or laser welding methods.
  • In another aspect of the present invention there is provided a packaged container, comprising a container containing a medicament powder; and an overwrap package enclosing the container and a desiccant; wherein the container and the desiccant are sealable within the overwrap. Preferably the overwrap comprises a desiccant material and/or is lined, coated or impregnated with a desiccant material.
  • The overwrap package may be in the form of a shrink wrap or of a loose wrap e.g. in sachet form. Any spare volume within the overwrap may be evacuated or an inert gas such as nitrogen deliberately inserted.
  • In another aspect of the present invention there is provided a packaged powder medicament dispenser (or reloadable cartridge therefor as described supra) comprising a medicament dispenser for a medicament powder; and an overwrap package enclosing the medicament dispenser, wherein the medicament dispenser are sealable within the overwrap. The overwrap package may comprise desiccant, and or the package may have desiccant contained therewithin. The medicament dispenser may comprise a powder reservoir or a medicament carrier for containment of medicament.
  • Where the overwrap comprises desiccant it may be impregnated or otherwise blended with material or added as a coating or a liner.
  • In another aspect, the body of said medicament dispenser also comprises a desiccant.
  • Preferably the desiccant is selected from the group consisting of silica gel, zeolite, alumina, bauxite, anhydrous calcium sulphate, activated bentonite clay, water-absorbing clay, molecular sieve, zinc chloride, and any mixtures thereof.
  • In another aspect of the present invention there is provided a container for a medicament powder formed from a material capable of controlling the ingress of moisture thereto or egress or moisture therefrom.
  • In one aspect, the material is impermeable to moisture.
  • In another aspect, the material controls the ingress or egress of moisture such that the ambient moisture content within the package is essentially constant, such as varying by no more than ±20%, preferably by less than ±10%.
  • In another aspect, the material enables moisture transfer in one way only i.e. ingress only or egress only.
  • In another aspect, the material enables moisture transfer to either a set minimum/maximum moisture content within the package or within a set minimum/maximum moisture transfer rate.
  • In another aspect, the material is also capable of controlling the flow of other gaseous or vapour form species.
  • In other aspects, the medicament container or overwrap therefor or any part of a medicament dispenser for use therewith is comprised of a material having desiccant blended or otherwise loaded or impregnated therein. Suitable materials are described in PCT Application Nos. WO99/62697 and WO/00/17258 in the name of Capitol Speciality Plastics Inc.
  • Suitable materials comprise a thermoplastic/desiccant blend. Examples of thermoplastics include polyolefin, polyethylene, polycarbonate, polyamide, ethylene-vinyl acetate copolymer, ethylene-methacrylate copolymer, polyvinyl chloride, polystyrene, polyester, polyester amide, polyacrylic ester, and polyvinylidene chloride, acrylic, polyurethane, polyacetal, and polycarbonate. These and other thermoplastics may be utilized either singularly, or in combinations.
  • The concentration of desiccant entrained (e.g. mixed or blended) within the thermoplastic may exceed seventy-five percent (75%) to not greater than eighty percent (80%) by weight, so that about seventy-five percent (75%) may extend to eighty percent (80%) by weight. Typically, however, the desiccant concentration will fall within a range of forty to seventy-five percent (40-75%) desiccant to thermoplastic, by weight. This concentration is considered to be a high concentration for most thermoplastics. The maximum desiccant bearable concentrations will vary among the various types of thermoplastics due to their differing characteristics. In the instance of polyethylene or polypropylene, for example, the maximum concentration of desiccant will be about seventy-five percent (75%) by weight. As the desiccant concentrations within the thermoplastics increase, the performance of the material degenerates to unacceptable levels. At lower levels of desiccant concentrations, about forty percent (40%) could extend to as low as thirty percent (30%) where the limits of a viable product are reached.
  • BRIEF DESCRIPTION OF INVENTION
  • FIG. 1 shows a medicament carrier in the form of a capsule according to the present invention.
  • FIG. 2 a is a cross-sectional side elevation of a single medicament blister strip impregnated with a desiccant according to the present invention.
  • FIG. 2 b is a top perspective of a medicament blister strip illustrated in FIG. 2 a.
  • FIG. 3 a is a cross-sectional side elevation of a single medicament blister having a laminate comprising a desiccant according to the present invention.
  • FIG. 3 b is a top perspective of a medicament blister strip illustrated in FIG. 3 a.
  • FIG. 4 a is a cross-sectional side elevation of a single medicament blister having a ring containing a desiccant impregnated into the laminate surrounding the blister pocket.
  • FIG. 4 b is a top perspective of the medicament blister shown in FIG. 4 a.
  • FIG. 5 shows a cross-sectional dry powder inhaler comprising a powder reservoir according the present invention.
  • FIG. 6 shows a cross-sectional dry powder inhaler comprising a medicament carrier according to the present invention.
  • FIG. 7 is a top perspective of a package for storing a dry powder inhaler according to the present invention.
  • FIG. 8 is a side perspective of the package of FIG. 7.
  • FIG. 9 is a cut-away bottom perspective of the package for storing a dry powder inhaler according to the present invention.
  • FIG. 10 is a cross-sectional view of the package for storing a dry powder inhaler according to the present invention.
  • DETAILED DESCRIPTION OF THE DRAWINGS
  • The medicament carrier in FIG. 1 is in the form of a capsule 1 comprising a wall 2 enclosing medicament powder 5. The wall 2 comprises a desiccant 3 which reduces or otherwise controls moisture ingress into the capsule 1 during storage and/or when in situ within the body of the inhaler (not shown). Medicament powder 5 is released on piercing the wall 2 of capsule 1 and may be inhaled by a patient.
  • FIG. 2 a shows a sectional side-elevation of a single blister strip 106 comprising a pocket 107, containing dry powder 105, base 110 and lid comprising laminates 114, 115. The lid is composed of a metallic foil laminate 114 bound to a plastic laminate 115. In the diagram, the lid 114, 115 is hermetically sealed to base 110 by appropriate means (e.g. adhesion, welding). Base 110 comprises an organic polymeric plastic impregnated with desiccant 103. In use, the desiccant absorbs any moisture which permeates through the lid 114, 115 and base 110, maintaining the powder 105 in a dry condition until the lid 114, 115 is removed from the base 110.
  • A top perspective of the blister strip 106 showing pockets 107 is illustrated in FIG. 2 b. Laminated lid 114, 115 is sealed to base 110 which is impregnated with desiccant 103.
  • FIG. 3 a shows a cross-sectional elevation of a different single blister strip 206 according to the invention. The blister strip 206 is composed of several laminated sheets, the lid being formed from metallic foil 214 and plastic laminate 215 while the base comprises plastic laminates 210 and 211. The plastic laminate 211 comprises a desiccant material 203 for absorbing any moisture which permeates through laminated sheets 214, 215 and 210, thereby reducing ingress into medicament powder 205 within pocket 207.
  • FIG. 3 b is a top perspective of a blister strip 206 showing several blisters as described in FIG. 3 a. Metallic foil 214 and plastic laminate 215 form a lid which is hermetically sealed, by appropriate adhesive or welding means, to the base of strip 206. The base comprises plastic laminates 210 and 211, laminate 211 being disposed on the internal surface of pocket 207 and comprising a desiccant.
  • FIG. 4 a shows a cross-sectional elevation of yet another single blister strip 306 according to the invention. Metallic foil 314 and plastic laminate 315 form a lid for base 310 which are hermetically sealed together to reduce moisture ingress into pocket 307 containing medicament powder 305. The circumference of pocket 307 is surrounded by a ring 319, within base 310, comprising desiccant 303 which absorbs moisture which permeates into the blister, particularly between lid sheet 315 and base sheet 310.
  • A plan perspective of the single blister strip 314 shown in FIG. 4 a is illustrated in FIG. 4 b. The ring 319 of material comprising desiccant 303 surrounds pocket 307 thereby absorbing any moisture which permeates into the pocket 307 through foil 314 and laminates 315 and/or base sheet 310, together with moisture ingress between lid and base sheets 315, 310.
  • FIG. 5 shows a sectional view of a dry powder inhaler 420 according to the present invention. The inhaler 420 comprises a body 421 which defines a reservoir 423 and a reservoir cover 424. The reservoir contains a supply of medicament in dry powder form 405. The walls 423 of the reservoir, defined by the body 421, are comprised of a desiccant material 403. Base 425 and body 421 define an aperture 430 through which powder 405 can pass from the reservoir to the dosing member 432. Powder 405 is guided by the walls 423 of the reservoir, which form a hopper, to the dosing member 432. Extending laterally from the lower end of the main body 421 is mouthpiece 435, through which the patient inhales via passage 433. If the device were intended for nasal inhalation this would be replaced by a nosepiece. The desiccant material 403, comprising walls 423, reduce moisture absorption by medicament powder 405. Optionally a desiccant comprising material may be located within the walls of passage 433 and/or a ring of same material around the metering valve (not shown) which controls the flow of medicament into passage 433.
  • FIG. 6 shows a simplified cross-sectional plan view of a dry powder inhaler comprising a medicament carrier according to the present invention. The inhaler 540 dispenses unit doses of medicament powder from a medicament blister strip 506. The inhaler is comprised of an outer casing 544 enclosing a medicament strip 506 within body 521. The medicament strip may be, for example, any of those described in FIGS. 2 a to 4 b above. The internal walls of body 521 are comprised of a desiccant material (not shown) which reduce the levels of moisture within the internal cavity of the inhaler, thereby protecting the medicament powder within strip 506. The patient uses the inhaler by holding the device to his mouth, depressing lever 538, and inhaling through mouthpiece 535. Depression of lever 538 activates the internal mechanism of the inhaler, such that the lid 514 and base 510 sheets of coiled medicament blister strip 506 are separated at index wheel 541 by use of contracting wheel 542 and base wheel 543. A unit dose of powdered medicament within blister pocket 507 is released and may be inhaled by the patient through exit port 533 and mouthpiece 535.
  • FIG. 7 shows a top perspective of a container storage system for storing a dry powder inhaler or cartridge refill therefor according to the present invention. The container storage system 650 includes a package or wrapping 652 that employs multi-layers of material 970, 972, 974. (See FIG. 10.) The package 652 further includes fin seams 654, 656 which are disposed along two parallel side edges of the package and along a single longitudinal edge of the package 652. The package 652 comprises a desiccant material, or alternatively is lined, coated or impregnated with a desiccant material.
  • The number and type of fin seams 654, 656 are not limited to the types shown in the drawings. The package 652 can include additional seams or significantly fewer seams such as a continuous single seam. The orientation of the seams 654, 656 is not limited to the orientation shown in the drawings. The orientation of the seams 654, 656 is typically a function of the sealing device and such seams may be oriented in a manner which substantially increases manufacturing efficiency. During manufacture, the longitudinal seam 654 may be formed first by heat sealing and the two end seams 656 may then be formed by heat sealing to close the package. Other types of seams include, but are not limited to, gusset type seams which include excess material which provides expansibility, stitched type seams, or mechanically crimped seams, and other like structures.
  • The container storage system includes a dry powder inhaler 820 (see FIG. 9). While the preferred inhaler is a dry powder inhaler 820, other dry powder inhalers (such as that described in FIG. 6) are not beyond the scope of the present invention.
  • FIG. 8 shows a side perspective of the container storage system of FIG. 7. The fin seams 654 and 656 in FIG. 7 are formed by a conventional heat sealing device which mechanically crimps sides of the package 750 together while simultaneously providing heat to the sides 654, 656/756 (FIGS. 7 and 8). The heat sealing device typically has electrical heater elements shaped to produce the pattern of the fin seams 654, 656/756 where the fin seams include multiple ridges 658/758. The sealing mechanism of the container storage system 650/750 of the present invention is not limited to heat sealing devices. Other sealing devices include, but are not limited to, glue sealing machines, sonic welding machines, electron beam radiation machines, and other like sealing devices.
  • As shown in FIG. 7, the package 750 preferably has a substantially rectangular configuration with a substantially elliptical cross section, however, other shapes of the package 750 are not beyond the scope of the present invention. Other shapes include, but are not limited to circular, square, triangular, trapezoidal, pentagonal, hexagonal, octagonal, and other like shapes. The shape of the package 750 is preferably a function of the shape of the enclosed medicament powder container 34 as well as the amount and type of storage space since the package 752 is made from flexible materials as will be described in further detail below.
  • FIG. 9 shows a cut-away bottom perspective of the package for storing a dry powder inhaler according to the present invention. The package 852 provides an enclosed volume 860 in which the inhaler 820 is disposed therein. The size of the enclosed volume 860 can be adjusted according to the size of the inhaler 820 and related parts thereto. Preferably, the enclosed volume 860 is of a size which permits relative ease of closing respective sides and layers 852, 26 and 28 without substantial stretching of the package 852. The enclosed volume 860 may be substantially evacuated prior to formation of the fin seams 858, 854 (not shown) to substantially reduce any water vapour being present in the enclosed volume 860. The enclosed volume 860 may be evacuated to such a degree that the enclosed volume 860 is a vacuum region around the medicament inhaler 820. While the enclosed volume 860, may remain constant, its relative shape may change according to shifting of the inhaler 820 disposed within the enclosed volume 860. In a preferred embodiment, a porous container of moisture absorbing material 862 lays adjacent to the mouthpiece 835 in a loose or free flowing manner. Alternatively, the moisture absorbing material 862 can be secured to the inside of the flexible package. In another alternative embodiment, the moisture absorbing container 862 may be attached to a bracket structure such as a ring which is fastened to the inhaler 820.
  • In one possible embodiment, the moisture absorbing material may be attached to the external surface of the mouthpiece 835 by a fastening device such as a rubber band 863. The fastening device 863 is preferably a removable elastic mechanism such as a rubber band. However, other fastening devices are not beyond the scope of the present invention. Other fastening devices include, but are not limited to, adhesives, adhesive tapes, shrink-wrap plastic, fasteners such as screws, nails, or rivets, compartments which are part of the mouthpiece housing 46, and other like attachment devices. In an alternative embodiment (not shown), a plurality of beads of material comprising a desiccant may be placed within the enclosed space 860. Similarly, other carriers comprised of a desiccant material may be enclosed within space 860 to absorb excess moisture from the enclosure.
  • FIG. 10 is a cross-sectional view of the package for storing a dry powder inhaler according to the present invention. The amorphous shape of the enclosed volume 960 is attributed to the flexible materials which make up the layers 970, 972, 974 of the package 952. The enclosed volume 960 can be varied in size such that it substantially conforms to the shape of the inhaler and any related parts thereto or such that the enclosed volume 960 is larger than the inhaler 820, as shown in FIG. 9. When the enclosed volume is of a size which is substantially equivalent with the surface area of the inhaler 820 and related parts, the layers 970, 972, and 974 of material substantially conform to the shape of the inhaler and related parts. The package is preferably placed in a separate, more rigid container, such as a paperboard or cardboard box (not shown) typically used in the pharmaceutical industry. The package may expand during storage due to slow leakage of volatiles from the plastics constituting the body of the inhaler. In this situation, the shape of the package may conform to some extent to the internal shape of the rigid container if the volume of the rigid container is just slightly larger than the expanded volume of the flexible package.
  • Flexible Packaging Materials
  • The flexible packaging material can be any material which is impervious to or substantially impervious to moisture. The packaging material is preferably permeable to volatiles which may escape from the plastics forming the body of the inhaler and/or the medicament carrier, by diffusion or otherwise, thereby preventing a build-up in pressure.
  • For ease of manufacturing, and in order to provide the necessary properties to the packaging material, the flexible packaging material preferably comprises a non-thermoplastic substrate (such as a metal foil) and a heat sealable layer disposed thereon, and an additional protective layer, such as a polymer film of polyester. The heat sealable layer is usually disposed on the inner surface of the assembled package. The additional protective layer is usually disposed on the surface opposite the heat sealable layer. An example of a particularly useful foil laminate is a polyester film adhesively laminated to aluminium foil adhesively laminated to Ionomer (SURLYN™) film, for example, 12μ polyester/9μ aluminum/50μ ionomer film supplied by Lawson Mardon Singen (LMS). To further reduce moisture ingress, thicker metal films, such as 20 to 25μ, may be used.
  • The substrate is preferably formed from aluminium foil. However, other metals for the substrate include, but are not limited to, tin, iron, zinc, or magnesium formed on a sheet by vacuum deposition or sputtering and a carboxyl group-containing polyolefin layer formed on the metal layer by lamination.
  • The heat sealable layer can be formed from any thermoplastic or thermosetting material such as an ionomer resin, polyolefin, or cycloolefin copolymer. Ionomer resins typically include ionically cross-linked ethylene-methacrylic acid and ethylene acrylic acid copolymers. Properties which distinguish these ionomers resins from other polyolefin heat-sealed polymers are high clarity, high impact resistance, low haze in lamination, tear resistance, abrasion resistance, solid state toughness, and moisture imperviousness. In the preferred embodiment, the heat sealable layer is made out of SURLYN™ (an ionomer resin) or a form of polyethylene to provide sufficient heat sealing properties.
  • The outer protective layer, if present, can be formed of any material as long as the final laminate has the requisite properties.
  • Preferably, the protective layer (e.g., polyester) is adhesively laminated to the substrate (e.g., aluminium) and the substrate layer in turn is adhesively laminated to the heat sealable layer (e.g., the ionomer film or SURLYN™ (an ionomer resin)). Preferred exemplary thicknesses of the three layers include a protective layer 1 to 40, preferably 4 to 30, more preferably 10 to 23 microns, and most preferably 12 microns; a substrate layer of 1 to 100, preferably 3 to 70, more preferably 5 to 50 microns, more preferably 6 to 20 microns, and most preferably 9 microns. For the heat sealable layer, preferred exemplary thicknesses include thicknesses of 1 to 100, preferably 5 to 70, more preferably 10 to 60, more preferably 20 to 55 microns, and most preferably 50 microns.
  • Adhesives may be used to join the respective layers of materials together. The adhesive layers are typically substantially smaller in thickness relative to the thickness of the substrate, heat sealable and/or protective layers which they bond. The number, size, and shape of the layers are not limited to those layers shown in the drawings. Any number of layers with relative areas of any size and predetermined thicknesses may be used so long as the flexible package forms an enclosed volume which substantially prevents ingression of water vapour and particulate matter into the enclosed volume while permitting egression out of the enclosed volume of any volatile released from the plastics used in the body of the inhaler or the medicament carrier. The size, shape, and number of layers of the package are typically a function of the size and contents of the inhaler and/or medicament carrier.
  • The package is believed to operate similarly to a virtual one-way valve due to the composition of the layers and due to the transmission rate of water vapour molecules into the enclosed volume relative to the transmission rate of gas molecules of a plastic volatile, such as formaldehyde, out of the enclosed volume. The package permits the volatile to diffuse out of the enclosed volume while substantially preventing water vapour and other particulate matter from entering the enclosed volume. Excess or leakage of the volatile is permitted to egress from the package. The virtual one-way valve function of the package prevents or minimizes the chance of any sudden ruptures or prevents or minimizes unexpected expulsion of the plastic volatile during opening of the package.
  • Moisture Absorbing Materials
  • The moisture absorbing material is preferably a silica gel desiccant sachet. However, other vapour or moisture absorbing mechanisms are not beyond the scope of the present invention. Other vapour or moisture absorbing materials include desiccants made from inorganic materials such a zeolites and aluminas. Such inorganic materials of vapour or moisture absorbing materials have high water absorption capacities and favourable water absorption isotherm shapes. The water absorption capacity of such materials typically varies from 20 to 50 weight percent. In the preferred embodiment, the absorbing material is a MINIPAX® supplied by Multisorb Technologies in the United States and Silgelac in Europe (silica gel packaged inside TYVEK®, which is a nylon mesh bonded with a microporous polyurethane). Other exemplary moisture absorbing materials include, but are not limited to, alumina, bauxite, anhydrous, calcium sulphate, water-absorbing clay, activated bentonite clay, a molecular sieve, or other like materials which optionally include a moisture sensitive colour indicator such as cobalt chloride to indicate when the desiccant is no longer operable. While in the preferred embodiment of the present invention, the package is designed to substantially prevent ingression of water vapour and particulate matter into the enclosed volume, the moisture absorbing material is placed within the enclosed volume in order to absorb any residual moisture present in the atmosphere or on the external surface of the pressurized container or mouthpiece or a combination thereof, prior to sealing the package.
  • The desiccant should be present in an amount sufficient to absorb any residual moisture inside the package. When silica gel is used, 1 g to 10 g of silica gel is sufficient for a typical dry powder inhaler. Moreover, the desiccant should be present in an amount sufficient to absorb any moisture that possibly ingresses from the external environment. It is also possible to place the desiccant inside the container, either loose in the canister or as part of an assembly attached to the canister.
  • Medicaments
  • Appropriate medicaments may thus be selected from, for example, analgesics, e.g., codeine, dihydromorphine, ergotamine, fentanyl or morphine; anginal preparations, e.g., diltiazem; antiallergics, e.g., cromoglycate (eg s the sodium salt), ketotifen or nedocromil (eg as the sodium salt); antiinfectives e.g., cephalosporins, penicillins, streptomycin, sulphonamides, tetracyclines and pentamidine; antihistamines, e.g., methapyrilene; anti-inflammatories, e.g., beclomethasone (eg as the dipropionate ester), fluticasone (eg as the propionate ester), flunisolide, budesonide, rofleponide, mometasone eg as the furoate ester), ciclesonide, triamcinolone (eg as the acetonide) or 6α,9α-difluoro-11β-hydroxy-16α-methyl-3-oxo-17α-propionyloxy-androsta-1,4-diene-17β-carbothioic acid S-(2-oxo-tetrahydro-furan-3-yl) ester; antitussives, e.g., noscapine; bronchodilators, e.g., albuterol (eg as free base or sulphate), salmeterol (eg as xinafoate), ephedrine, adrenaline, fenoterol (eg as hydrobromide), formoterol (eg as fumarate), isoprenaline, metaproterenol, phenylephrine, phenylpropanolamine, pirbuterol (eg as acetate), reproterol (eg as hydrochloride), rimiterol, terbutaline (eg as sulphate), isoetharine, tulobuterol or 4-hydroxy-7-[2-[[2-[[3-(2-phenylethoxy)propyl]sulfonyl]ethyl]amino]ethyl-2(3H)-benzothiazolone; adenosine 2a agonists, eg 2R,3R,4S,5R)-2-[6-Amino-2-(1S-hydroxymethyl-2-phenyl-ethylamino)-purin-9-yl]-5-(2-ethyl-2H-tetrazol-5-yl)-tetrahydro-furan-3,4-diol (e.g. as maleate); α4 integrin inhibitors eg (2S)-3-[4-({[4-(aminocarbonyl)-1-piperidinyl]carbonyl}oxy)phenyl]-2-[((2S)-4-methyl-2-{[2-(2-methylphenoxy)acetyl]amino}pentanoyl)amino] propanoic acid (e.g as free acid or potassium salt), diuretics, e.g., amiloride; anticholinergics, e.g., ipratropium (eg as bromide), tiotropium, atropine or oxitropium; hormones, e.g., cortisone, hydrocortisone or prednisolone; xanthines, e.g., aminophylline, choline theophyllinate, lysine theophyllinate or theophylline; therapeutic proteins and peptides, e.g., insulin or glucagon; vaccines, diagnostics, and gene therapies. It will be clear to a person skilled in the art that, where appropriate, the medicaments may be used in the form of salts, (e.g., as alkali metal or amine salts or as acid addition salts) or as esters (e.g., lower alkyl esters) or as solvates (e.g., hydrates) to optimise the activity and/or stability of the medicament.
  • Preferred medicaments are selected from albuterol, salmeterol, fluticasone propionate and beclomethasone dipropionate and salts or solvates thereof, e.g., the sulphate of albuterol and the xinafoate of salmeterol.
  • Medicaments can also be delivered in combinations. Preferred formulations containing combinations of active ingredients contain salbutamol (e.g., as the free base or the sulphate salt) or salmeterol (e.g., as the xinafoate salt) or formoterol (eg as the fumarate salt) in combination with an antiinflammatory steroid such as a beclomethasone ester (e.g., the dipropionate) or a fluticasone ester (e.g., the propionate) or budesonide. A particularly preferred combination is a combination of fluticasone propionate and salmeterol, or a salt thereof (particularly the xinafoate salt). A further combination of particular interest is budesonide and formoterol (e.g. as the fumarate salt).
  • It may be appreciated that any of the parts of the medicament container used therewith which contact the medicament may be coated with materials such as fluoropolymer materials which reduce the tendency of medicament to adhere thereto. Suitable fluoropolymers include polytetrafluoroethylene (PTFE) and fluoroethylene propylene (FEP). Any movable parts may also have coatings applied thereto which enhance their desired movement characteristics. Frictional coatings may therefore be applied to enhance frictional contact and lubricants used to reduce frictional contact as necessary.
  • It will be understood that the present disclosure is for the purpose of illustration only and the invention extends to modifications, variations and improvements thereto.
  • The application of which this description and claims form part may be used as a basis for priority in respect of any subsequent application. The claims of such subsequent application may be directed to any feature or combination of features described therein. They may take the form of product, method or use claims and may include, by way of example and without limitation, one or more of the following claims:

Claims (22)

1.-26. (canceled)
27. A package for storage of a container for a medicament powder formed from a material capable of controlling the ingress of moisture thereto or egress of moisture therefrom such that the moisture content within the package is essentially constant.
28. (canceled)
29. A package according to claim 27, wherein the material enables moisture transfer in one way only.
30. A package according to claim 27, wherein the material enables moisture transfer to a set maximum or minimum level within the package.
31. A package according to claim 27, wherein the material enables moisture transfer within a set maximum or minimum transfer rate.
32. A package according to claim 27, wherein said package is wrappable and sealable around the container to form an enclosed volume in which the container is disposed, thereby controlling ingress or egress of moisture.
33. A package according to claim 32, additionally comprising a desiccant within the enclosed volume.
34. A package according to claim 33, wherein said desiccant is selected from the group consisting of silica gel, zeolite, alumina, bauxite, anhydrous calcium sulphate, activated bentonite clay, water-absorbing clay, molecular sieve and any mixtures thereof.
35. A package according to claim 27 wherein the package includes at least one heat sealable layer and at least one layer of a metal foil.
36. A package according to claim 35, wherein the metal comprising said metal foil is selected from the group consisting of aluminium, tin, iron, zinc and magnesium.
37. A package according to claim 36, wherein the package includes protective layers located on the outside of the package.
38. A package according to claim 37, wherein said protective layer comprises a polyester film and said heat sealable layer comprises an ionomer film.
39. A method of storing a container for a medicament powder comprising
providing a packaging material;
filling a container with a medicament powder;
wrapping said container with said package material to form an enclosed volume in which said container is disposed therein; and
sealing the package,
characterized in that said packaging material is capable of controlling the ingress of moisture to or egress of moisture from said enclosed volume such that the moisture content within the package is essentially constant.
40. A method of storing a container for a medicament powder according to claim 39, additionally comprising providing a desiccant within the enclosed volume.
41. A method according to claim 39, wherein said sealing comprises sealing said packaging material using a method selected from the group consisting of heat sealing, ultrasonic welding, laser welding, adhesive sealing and heat stamping.
42-46. (canceled)
47. A container for a medicament powder formed from a material capable of controlling the ingress of moisture thereto or egress of moisture therefrom such that the moisture content within the package is essentially constant.
48. (canceled)
49. A container according to claim 47, wherein the material enables moisture transfer in one way only.
50. A container according to claim 47, wherein the material enables moisture transfer to a set maximum or minimum level within the package.
51. A container according to claim 47, wherein the material enables moisture transfer within a set maximum or minimum transfer rate.
US11/427,370 2000-06-21 2006-06-29 Container for Medicament Powder Abandoned US20060249419A1 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
GB0015043A GB0015043D0 (en) 2000-06-21 2000-06-21 Medicament dispenser
GB0015043.3 2000-06-21
PCT/EP2001/006303 WO2001098174A1 (en) 2000-06-21 2001-06-05 Container for medicament powder
US10/276,932 US7828150B2 (en) 2000-06-21 2001-06-05 Container for medicament powder
US11/427,370 US20060249419A1 (en) 2000-06-21 2006-06-29 Container for Medicament Powder

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US11/427,370 US20060249419A1 (en) 2000-06-21 2006-06-29 Container for Medicament Powder

Related Parent Applications (2)

Application Number Title Priority Date Filing Date
PCT/EP2001/006303 Continuation WO2001098174A1 (en) 2000-06-21 2001-06-05 Container for medicament powder
US10/276,932 Continuation US7828150B2 (en) 2000-06-21 2001-06-05 Container for medicament powder

Publications (1)

Publication Number Publication Date
US20060249419A1 true US20060249419A1 (en) 2006-11-09

Family

ID=9894007

Family Applications (2)

Application Number Title Priority Date Filing Date
US10/276,932 Active 2022-10-22 US7828150B2 (en) 2000-06-21 2001-06-05 Container for medicament powder
US11/427,370 Abandoned US20060249419A1 (en) 2000-06-21 2006-06-29 Container for Medicament Powder

Family Applications Before (1)

Application Number Title Priority Date Filing Date
US10/276,932 Active 2022-10-22 US7828150B2 (en) 2000-06-21 2001-06-05 Container for medicament powder

Country Status (14)

Country Link
US (2) US7828150B2 (en)
EP (2) EP1292510B2 (en)
JP (1) JP2003535782A (en)
CN (1) CN1437551A (en)
AT (1) AT353834T (en)
AU (1) AU7408601A (en)
BR (1) BR0111252A (en)
CA (1) CA2411109A1 (en)
DE (1) DE60126609T3 (en)
ES (1) ES2282261T3 (en)
GB (1) GB0015043D0 (en)
MX (1) MXPA02012680A (en)
WO (1) WO2001098174A1 (en)
ZA (1) ZA200208212B (en)

Cited By (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080092887A1 (en) * 2004-12-07 2008-04-24 Hodson Peter D Single-Dose Inhalation Devices
US20090235929A1 (en) * 2008-03-19 2009-09-24 Marc Egen Powder inhalers
US20110120464A1 (en) * 2008-01-11 2011-05-26 Innovata Biomed Limited Inhalers
US20110174665A1 (en) * 2007-04-27 2011-07-21 Daiwa Can Company Polyester Resin Container With Fracturable Portion And Its Production Method
US20110203586A1 (en) * 2008-02-20 2011-08-25 Boehringer Ingelheim International Gmbh Powder Inhalers
US20120179094A1 (en) * 2009-07-14 2012-07-12 Sanofi-Aventis Deutschland Gmbh Medicament container
US20120248005A1 (en) * 2011-04-01 2012-10-04 Mannkind Corporation Blister Package for Pharmaceutical Cartridges
US20130032145A1 (en) * 2008-05-01 2013-02-07 Dan Adler Dry powder inhaler
US20130153459A1 (en) * 2010-09-01 2013-06-20 Kyodo Printing Co., Ltd. Package
US20150083747A1 (en) * 2007-08-17 2015-03-26 Noble Innovations Llc Toothbrush system utilizing oral care capsule
US9192675B2 (en) 2008-06-13 2015-11-24 Mankind Corporation Dry powder inhaler and system for drug delivery
US9220687B2 (en) 2008-12-29 2015-12-29 Mannkind Corporation Substituted diketopiperazine analogs for use as drug delivery agents
US9233159B2 (en) 2011-10-24 2016-01-12 Mannkind Corporation Methods and compositions for treating pain
US9241903B2 (en) 2006-02-22 2016-01-26 Mannkind Corporation Method for improving the pharmaceutic properties of microparticles comprising diketopiperazine and an active agent
US9283193B2 (en) 2005-09-14 2016-03-15 Mannkind Corporation Method of drug formulation based on increasing the affinity of crystalline microparticle surfaces for active agents
US9364619B2 (en) 2008-06-20 2016-06-14 Mannkind Corporation Interactive apparatus and method for real-time profiling of inhalation efforts
US9364436B2 (en) 2011-06-17 2016-06-14 Mannkind Corporation High capacity diketopiperazine microparticles and methods
US9630930B2 (en) 2009-06-12 2017-04-25 Mannkind Corporation Diketopiperazine microparticles with defined specific surface areas
US9662461B2 (en) 2008-06-13 2017-05-30 Mannkind Corporation Dry powder drug delivery system and methods
US9675674B2 (en) 2004-08-23 2017-06-13 Mannkind Corporation Diketopiperazine salts for drug delivery and related methods
US9700690B2 (en) 2002-03-20 2017-07-11 Mannkind Corporation Inhalation apparatus
US9706944B2 (en) 2009-11-03 2017-07-18 Mannkind Corporation Apparatus and method for simulating inhalation efforts
US9796688B2 (en) 2004-08-20 2017-10-24 Mannkind Corporation Catalysis of diketopiperazine synthesis
US9801925B2 (en) 1999-06-29 2017-10-31 Mannkind Corporation Potentiation of glucose elimination
US9802012B2 (en) 2012-07-12 2017-10-31 Mannkind Corporation Dry powder drug delivery system and methods
US9925144B2 (en) 2013-07-18 2018-03-27 Mannkind Corporation Heat-stable dry powder pharmaceutical compositions and methods
US9943571B2 (en) 2008-08-11 2018-04-17 Mannkind Corporation Use of ultrarapid acting insulin
US9983108B2 (en) 2009-03-11 2018-05-29 Mannkind Corporation Apparatus, system and method for measuring resistance of an inhaler
US10159644B2 (en) 2012-10-26 2018-12-25 Mannkind Corporation Inhalable vaccine compositions and methods

Families Citing this family (62)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7171965B2 (en) * 2000-02-01 2007-02-06 Valois S.A.S. Breath actuated dry powder inhaler and tape dose strip
EP1241110A1 (en) * 2001-03-16 2002-09-18 Pfizer Products Inc. Dispensing unit for oxygen-sensitive drugs
SE0101825D0 (en) * 2001-05-22 2001-05-22 Astrazeneca Ab An inhalation device
AT402091T (en) * 2001-11-17 2008-08-15 Aventis Pharma Ltd product pharmaceutical and process with adsorber
GB0130857D0 (en) * 2001-12-22 2002-02-06 Glaxo Group Ltd Medicament dispenser
US7258118B2 (en) 2002-01-24 2007-08-21 Sofotec Gmbh & Co, Kg Pharmaceutical powder cartridge, and inhaler equipped with same
US20030235538A1 (en) * 2002-04-09 2003-12-25 Boehringer Ingelheim Pharma Gmbh & Co. Kg Method for the administration of an anticholinergic by inhalation
CA2483914A1 (en) * 2002-05-07 2003-11-20 Nektar Therapeutics Capsules for dry powder inhalers and methods of making and using same
US7025205B2 (en) * 2002-06-26 2006-04-11 Aventis Pharma Limited Method and packaging for pressurized containers
GB0225621D0 (en) 2002-11-02 2002-12-11 Glaxo Group Ltd Medicament carrier
EP1572217B1 (en) 2002-12-12 2008-08-20 Nycomed GmbH Combination medicament of r,r-formoterol and ciclesonide
DK1616549T3 (en) * 2003-04-23 2012-11-05 Otsuka Pharma Co Ltd Plastic ampoule filling a drug solution and the process for its preparation
GB0312148D0 (en) * 2003-05-28 2003-07-02 Aventis Pharma Ltd Stabilized pharmaceutical products
GB0315889D0 (en) 2003-07-08 2003-08-13 Aventis Pharma Ltd Stable pharmaceutical products
US8371292B2 (en) 2003-09-16 2013-02-12 Nycomed Gmbh Use of ciclesonide for the treatment of respiratory diseases
SE0303270A (en) * 2003-12-03 2005-06-04 Microdrug Ag Method for administration of tiotropium
SE0303569A (en) * 2003-12-03 2005-06-04 Microdrug Ag DPI delivery of moisture sensitive medicament
SE0303571D0 (en) * 2003-12-03 2003-12-22 Microdrug Ag Medical product for moisture-sensitive medicaments
SE0303570A (en) * 2003-12-03 2005-06-04 Microdrug Ag Moisture-sensitive medical product
SE0303269A (en) * 2003-12-03 2005-06-04 Microdrug Ag medical product
FR2864944B1 (en) * 2004-01-14 2006-03-31 Valois Sas Blister strip inhaler.
SE530006C2 (en) * 2004-06-18 2008-02-05 Mederio Ag Inhaler using pods
SE0401654D0 (en) * 2004-06-24 2004-06-24 Astrazeneca Ab A support structure for a medicament
UA95063C2 (en) * 2004-10-21 2011-07-11 Бёрингер Ингельхайм Интернациональ Гмбх Blister for inhalers
FR2877925B1 (en) * 2004-11-16 2008-09-19 Valois Sas A fluid dispenser.
FR2881119B1 (en) * 2005-01-25 2010-07-30 Valois Sas A fluid dispenser.
CN100431634C (en) 2005-04-04 2008-11-12 陈庆堂;陈 欣 Dry powder aerosolizing inhalator
GB2425115A (en) * 2005-04-15 2006-10-18 Vectura Group Plc Blister pack
JP4659523B2 (en) * 2005-04-26 2011-03-30 共同印刷株式会社 Packaging container for a blister film and blister
TWI274641B (en) * 2005-08-30 2007-03-01 Rexon Ind Corp Ltd Cutting machine
US20070114237A1 (en) * 2005-11-23 2007-05-24 Canegallo Pirottavio System and method to dispense single capsular bodies
WO2007089477A2 (en) * 2006-01-31 2007-08-09 Oriel Therapeutics, Inc. Dry powder inhalers having spiral travel paths, unit dose microcartridges with dry powder, related devices and methods
EP2020249A1 (en) * 2007-08-01 2009-02-04 Boehringer Ingelheim Pharma GmbH & Co. KG Inhalator
HUE027246T2 (en) * 2008-01-24 2016-10-28 Vectura Delivery Devices Ltd Inhaler
ES2396735T3 (en) * 2008-03-05 2013-02-25 Rivopharm Sa Nicorandil vehicles with improved stability
DE102008018629A1 (en) * 2008-04-11 2009-10-15 Alcan Technology & Management Ag Packaging film portion, packaging film, packaging and packing product unit
US20090295108A1 (en) * 2008-05-22 2009-12-03 Albert Hisayuki Oku Mobile Ball Hopper and Sport Bag Carrier
EP2145758B2 (en) 2008-07-14 2017-06-07 3A Technology & Management AG Packaging and packaging unit
US8919341B2 (en) * 2008-12-03 2014-12-30 Boehringer Ingelheim International Gmbh Inhaler
KR100896958B1 (en) 2009-02-12 2009-05-12 주식회사 제알코 Packaging structure of medical supplies and packing method thereof
TR200908847A2 (en) 2009-11-23 2011-06-21 Bilgiç Mahmut blister pack with dry powder medication.
EP2611423B1 (en) 2010-08-31 2015-06-24 GlaxoSmithKline Intellectual Property Development Limited Dry powder inhalation drug products exhibiting moisture control properties and methods of administering the same
EP2611422B1 (en) * 2010-08-31 2018-10-31 GlaxoSmithKline Intellectual Property Development Limited Dry powder inhalation drug products exhibiting moisture control properties and methods of administering the same
US8785183B2 (en) 2010-09-21 2014-07-22 Biogaia Ab Active plastic material in oil
US9101305B2 (en) * 2011-03-09 2015-08-11 Medtronic Minimed, Inc. Glucose sensor product and related manufacturing and packaging methods
MY165888A (en) 2012-01-25 2018-05-18 Chiesi Farm Spa Dry powder formulation comprising a corticosteroid and a beta-adrenergic for administration by inhalation
USD693695S1 (en) 2012-03-28 2013-11-19 Aventisub Ii Inc. Package for product
USD697813S1 (en) 2012-03-28 2014-01-21 Aventisub Ii Inc. Clamshell having blisters received therein
USD687313S1 (en) 2012-03-28 2013-08-06 Aventisub Ii Inc. A-shaped blister card
US8919559B2 (en) 2012-03-28 2014-12-30 Aventisub Ii Inc. Package with break-away clamshell
US8899419B2 (en) 2012-03-28 2014-12-02 Aventisub Ii Inc. Package with break-away clamshell
USD695625S1 (en) 2012-03-28 2013-12-17 Aventisub Ii Inc. Package for product
USD694644S1 (en) 2012-03-28 2013-12-03 Aventisub Ii Inc. Clamshell package having blisters
WO2013176635A1 (en) 2012-05-25 2013-11-28 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Inhaler device having an improved guide gear
DK3019153T3 (en) 2013-07-11 2018-11-19 Chiesi Farm Spa Dry powder formulation comprising an anticholinergic agent, a corticosteroid and a beta-adrenergikum for administration by inhalation
BR112016022189A2 (en) * 2014-03-27 2017-10-17 Avantor Performance Mat Inc Packaging system and method to inhibit moisture penetration
US9554992B2 (en) 2014-06-09 2017-01-31 Chiesi Farmaceutici S.P.A. Inhalation particles comprising a combination of an anticholinergic, a corticosteroid and a beta-adrenergic
KR101481733B1 (en) * 2014-06-30 2015-01-12 주식회사 선양 Dehumidifying and deodorizing functional compound having a three-layer packaging film and its manufacturing method
KR20180082443A (en) 2015-11-16 2018-07-18 키에시 파르마슈티시 엣스. 피. 에이. Method of manufacturing a dry powdered preparation comprising an adrenergic drug - anticholinergics, corticosteroids and beta
SG11201804048WA (en) 2015-11-16 2018-06-28 Chiesi Farm Spa A process for preparing a dry powder formulation comprising an anticholinergic, a corticosteroid and a beta-adrenergic
WO2018206618A1 (en) 2017-05-11 2018-11-15 Chiesi Farmaceutici S.P.A. A process for preparing a dry powder formulation comprising an anticholinergic, a corticosteroid and a beta-adrenergic
WO2018206619A1 (en) 2017-05-11 2018-11-15 Chiesi Farmaceutici S.P.A. A process for preparing a dry powder formulation comprising an anticholinergic, a corticosteroid and a beta-adrenergic

Citations (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3333683A (en) * 1966-02-17 1967-08-01 Anaconda Aluminum Co Cigarette package
US3371825A (en) * 1966-05-12 1968-03-05 Multiform Desiccant Products I Sorptive getter for pressure discharge dispensers
US3670874A (en) * 1968-12-05 1972-06-20 Sulzer Ag Method for irradiating foodstuffs and other consumables, pharmaceuticals and the like, and a package for same
US3704806A (en) * 1971-01-06 1972-12-05 Le T Im Lensoveta Dehumidifying composition and a method for preparing the same
US3738540A (en) * 1970-04-01 1973-06-12 Oreal Container for corrosive products to be stored under pressure
US3788322A (en) * 1972-12-27 1974-01-29 Alza Corp Drug delivery device with means for maintaining device in environment of use
US3797492A (en) * 1972-12-27 1974-03-19 Alza Corp Device for dispensing product with directional guidance member
US3809223A (en) * 1971-08-27 1974-05-07 Crown Zellerbach Corp Protected lumber package and method of making same
US4042170A (en) * 1975-05-06 1977-08-16 Ab Svenska Dental Instrument Sterile package
US4135622A (en) * 1973-03-28 1979-01-23 American Cyanamid Company Packaged, desiccated surgical elements
US4305502A (en) * 1977-07-20 1981-12-15 John Wyeth & Brother Limited Pharmaceutical dosage form packges
US4363841A (en) * 1981-12-28 1982-12-14 Champion International Corporation Laminated packaging material
US4447565A (en) * 1981-12-07 1984-05-08 The United States Of America As Represented By The United States Department Of Energy Method and composition for molding low density desiccant syntactic foam articles
US4449832A (en) * 1981-03-20 1984-05-22 Dieter Graesslin Feinwerktechnik Program input and/or time setting device
US5560490A (en) * 1992-09-09 1996-10-01 Fisons Plc Pharmaceutical packaging with capsule sealing means
US6279736B1 (en) * 1995-04-19 2001-08-28 Capitol Specialty Plastics, Inc. Barrier pack having an absorbing agent applied to the interior of the pack
US20030235664A1 (en) * 2002-06-20 2003-12-25 Rick Merical Films having a desiccant material incorporated therein and methods of use and manufacture
US20040131805A1 (en) * 2002-06-20 2004-07-08 Merical Rick L. Films having a desiccant material incorporated therein and methods of use and manufacture
US20060134007A1 (en) * 2004-10-21 2006-06-22 Boehringer Ingelheim International Gmbh Blister for inhalers
US20060269708A1 (en) * 2002-06-20 2006-11-30 Rick Merical Films having a desiccant material incorporated therein and methods of use and manufacture

Family Cites Families (128)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US577532A (en) * 1897-02-23 Annunciator
US2524162A (en) 1945-02-27 1950-10-03 Chavannes Marc Alfred Desiccant packaging
US2517482A (en) * 1949-04-09 1950-08-01 Sharp & Dohme Inc Inhaler
FR1398104A (en) * 1964-03-26 1965-05-07 Participations Et Procedes Ind dehydrating elements and their manufacturing process
CH434104A (en) * 1964-05-01 1967-04-15 Schuepbach Ag A conditioning packaging material
US3921805A (en) * 1972-10-10 1975-11-25 Newton L Compere Rupturable blister pill package with safety backing
US4274403A (en) * 1979-08-29 1981-06-23 Struve Roger L Inhaler
US4702963A (en) 1981-04-03 1987-10-27 Optical Coating Laboratory, Inc. Flexible polymer film with vapor impermeable coating
US4429792A (en) * 1981-09-11 1984-02-07 Medication Services, Inc. Medication-dispensing card
US4447585A (en) * 1982-03-04 1984-05-08 The Goodyear Tire & Rubber Company Polymer bound aryl substituted crown ethers
US4449632A (en) 1982-12-15 1984-05-22 Marusiak Jr Frank Tamper-proof package and method
US4570820A (en) 1983-01-18 1986-02-18 Creative Products Resource Associates, Ltd. Resealable dispensing container for folded towels
ZW6584A1 (en) 1983-04-18 1985-04-17 Glaxo Group Ltd Phenethanolamine derivatives
US4509196A (en) 1983-06-30 1985-04-02 Arvey Corporation Tamper-indicating self-sealing pouch
US4664256A (en) 1983-09-06 1987-05-12 Farmaceutisk Laboratorium Ferring A/S Packaged stable enema solution or suspension containing 5-aminosalicyclic acid
US4655229A (en) 1984-01-30 1987-04-07 R. J. Reynolds Tobacco Company Flavor delivery system
US5743398A (en) 1984-05-22 1998-04-28 Southpac Trust International, Inc. Floral wrapper utilizing a breathable packaging material
US6022627A (en) 1993-08-17 2000-02-08 Southpac Trust International, Inc. Floral wrapper utilizing a breathable packaging material
SE465417B (en) 1984-06-21 1991-09-09 Toyo Seikan Kaisha Ltd Plastbehaallare framstaelld of laminate comprising a gasbarriaerskikt
US4665229A (en) * 1985-02-14 1987-05-12 Ashland Oil, Inc. Preparation of hydroxy alkyl amide thio ether compounds from bicyclic amide acetal and thiol
US4645073A (en) 1985-04-02 1987-02-24 Survival Technology, Inc. Anti-contamination hazardous material package
DE3524846A1 (en) 1985-07-12 1987-01-15 Hoechst Ag Packaging for dry resist material
US4938238A (en) 1985-08-26 1990-07-03 R. J. Reynolds Tobacco Company Smoking article with improved wrapper
US5073599A (en) 1985-11-29 1991-12-17 American National Can Company Films using blends of polypropylene and polyisobutylene
DE8605885U1 (en) 1986-03-04 1986-04-17 Eurim-Pharm Arzneimittel Gmbh, 8235 Piding, De
DE3610345C2 (en) 1986-03-27 1998-07-09 Rathor Ag Device for producing polyurethane assembly foam
US4720423A (en) 1986-08-25 1988-01-19 Minnesota Mining And Manufacturing Company Package opening system
US4757919A (en) 1986-09-23 1988-07-19 The Coca-Cola Company Shut-off valve for juice dispensing system
US4718553A (en) 1987-02-11 1988-01-12 Ivy Hill Corporation Tamper-evident packaging, method of making same, and intermediate therein
DE3715938A1 (en) 1987-05-13 1988-11-24 Boehringer Mannheim Gmbh test strip capacities for
CA1329526C (en) 1987-08-20 1994-05-17 Hiroshi Ikura Powdery medicine applicator device
US4815602A (en) 1987-10-30 1989-03-28 W.R. Grace & Co. Vacuum skin package for closing two moisture impervious metallic sheets about a product
US4802583A (en) 1988-03-11 1989-02-07 The Mead Corporation Article container with overwrap
US4811571A (en) 1988-03-28 1989-03-14 Thermo King Corporation Refrigerant drier
US4861632A (en) 1988-04-19 1989-08-29 Caggiano Michael A Laminated bag
US4907394A (en) 1988-05-27 1990-03-13 Unionpack Industrielle Lohnverpackuns-Gmbh & Co. Method for producing a foil-container, apparatus for the implementation of the said method, and a foil-container produced according to the said method
JP2592500B2 (en) 1988-06-01 1997-03-19 三井石油化学工業株式会社 Laminated film
US5062569A (en) 1988-08-01 1991-11-05 Hekal Ihal M Peelably sealed plastic packages and method of preparing same
US4934524A (en) 1988-09-19 1990-06-19 Brown & Williamson Tobacco Corporation Package for storing moisture laden articles
US5186775A (en) 1988-10-05 1993-02-16 Cullen John S Method of fabrication of a container for bulk material
US4874090A (en) 1988-10-24 1989-10-17 American Sterilizer Company Self-seal sterilization pouch
GB8828477D0 (en) 1988-12-06 1989-01-05 Riker Laboratories Inc Medical aerosol formulations
US5035935A (en) 1989-01-19 1991-07-30 Philip Morris Incorporated Overwrap insert
US5718355A (en) 1989-02-03 1998-02-17 Senetics, Inc. Indicator device responsive to axial force for use with inhaler
GB8909891D0 (en) 1989-04-28 1989-06-14 Riker Laboratories Inc Device
US4972953A (en) 1989-06-14 1990-11-27 Ivy Hill Corporation Tamper-evident packaging, method of making same and intermediate therein
GB8919131D0 (en) 1989-08-23 1989-10-04 Riker Laboratories Inc Inhaler
US5270305A (en) 1989-09-08 1993-12-14 Glaxo Group Limited Medicaments
GB8925707D0 (en) 1989-11-14 1990-01-04 Riker Laboratories Inc Device
US5113855A (en) 1990-02-14 1992-05-19 Newhouse Michael T Powder inhaler
US5201308A (en) 1990-02-14 1993-04-13 Newhouse Michael T Powder inhaler
US6536427B2 (en) 1990-03-02 2003-03-25 Glaxo Group Limited Inhalation device
DE4013799C2 (en) 1990-04-28 1993-01-21 Gaplast Gmbh, 8111 Saulgrub, De
US5192548A (en) * 1990-04-30 1993-03-09 Riker Laboratoires, Inc. Device
US5126123A (en) 1990-06-28 1992-06-30 Glaxo, Inc. Aerosol drug formulations
US5304419A (en) 1990-07-06 1994-04-19 Alpha Fry Ltd Moisture and particle getter for enclosures
DE4027391A1 (en) 1990-08-30 1992-03-12 Boehringer Ingelheim Kg LPG Free inhalationsgeraet
US5042472A (en) * 1990-10-15 1991-08-27 Merck & Co., Inc. Powder inhaler device
US5394868A (en) 1992-06-25 1995-03-07 Schering Corporation Inhalation device for powdered medicaments
DK0592540T3 (en) 1991-07-02 2000-06-26 Inhale Inc Method and device for delivering aerosolized medications
US6029661A (en) 1991-08-26 2000-02-29 3M Innovative Properties Company Powder dispenser
US5916540A (en) 1994-10-24 1999-06-29 Glaxo Group Limited Aerosol formulations containing P134A and/or P227 and particulate medicament
IL104068A (en) 1991-12-12 1998-10-30 Glaxo Group Ltd Surfactant-free pharmaceutical aerosol formulation comprising 1,1,1,2-tetrafluoroethane or 1,1,1,2,3,3,3-heptafluoro-n- propane as propellant
GB9203761D0 (en) * 1992-02-21 1992-04-08 Innovata Biomed Ltd Inhaler
US5330047A (en) 1992-04-27 1994-07-19 Rhone-Poulenc Inc. Packaging for agrichemicals
CA2099940A1 (en) 1992-07-06 1994-01-07 Kenneth A. Thomas Tear tape
US5814337A (en) * 1992-10-07 1998-09-29 Beecham Group Plc Pharmaceutical formulation
GB2272162B (en) 1992-11-06 1996-10-09 Paul Richard Yerbury Dust proof inhaler
US5322161A (en) 1992-11-30 1994-06-21 United States Surgical Corporation Clear package for bioabsorbable articles
CZ287848B6 (en) 1992-12-18 2001-02-14 Schering Corp Inhalator of powder substances
US5756171A (en) 1992-12-22 1998-05-26 Kabushiki Kaisha Hosokawa Yoko Laminate film and method of producing the same
US5441060A (en) 1993-02-08 1995-08-15 Duke University Dry powder delivery system
GB9306703D0 (en) 1993-03-31 1993-05-26 Fisons Plc Inhalation device
AU695969B2 (en) 1993-04-30 1998-08-27 Minnesota Mining And Manufacturing Company Seal configuration for aerosol canister
JPH0796977A (en) 1993-06-08 1995-04-11 Ajinomoto Co Inc Double packing material for easily oxidized substance
US5451437A (en) 1993-06-21 1995-09-19 Minnesota Mining And Manufacturing Company Method and article for protecting a container that holds a fluid
JPH0733172A (en) * 1993-07-08 1995-02-03 Toppan Printing Co Ltd Multi-layer plastic container
US5524613A (en) 1993-08-25 1996-06-11 Habley Medical Technology Corporation Controlled multi-pharmaceutical inhaler
GB9404945D0 (en) * 1994-03-15 1994-04-27 Glaxo Group Ltd Pharmaceutical composition
GB9405249D0 (en) * 1994-03-17 1994-04-27 Smithkline Beecham Plc Container
US5472092A (en) 1994-03-30 1995-12-05 H. J. Heinz Company Shrink wrapped package and method for its production
GB9411626D0 (en) * 1994-06-10 1994-08-03 Smithkline Beecham Plc Package
TW272163B (en) 1994-06-24 1996-03-11 Mitsubishi Gas Chemical Co
DE69528912D1 (en) 1994-09-16 2003-01-02 Glaxosmithkline Lab Sas inhaler
US5522385A (en) 1994-09-27 1996-06-04 Aradigm Corporation Dynamic particle size control for aerosolized drug delivery
US5551557A (en) 1994-10-25 1996-09-03 Convey, Inc. Efficient method and apparatus for establishing shelf-life of getters utilized within sealed enclosures
US5565164A (en) * 1995-03-17 1996-10-15 Limited Resources, Inc. Method and apparatus for densifying a thermoplastic polymer
HU219900B (en) 1995-04-14 2001-09-28 Glaxo Wellcome Inc. Metered dose inhaler
DE69636757T2 (en) 1995-04-14 2007-10-11 Smithkline Beecham Corp. Metered dose inhaler for Fluticasonepropionat
DE69630819D1 (en) * 1995-04-19 2003-12-24 Csp Technologies Inc A sealed container with desiccant
US6194079B1 (en) 1995-04-19 2001-02-27 Capitol Specialty Plastics, Inc. Monolithic polymer composition having an absorbing material
US5911937A (en) 1995-04-19 1999-06-15 Capitol Specialty Plastics, Inc. Desiccant entrained polymer
US5645051A (en) 1995-04-21 1997-07-08 Dura Pharmaceuticals, Inc. Unit dose dry powder inhaler
US5622166A (en) * 1995-04-24 1997-04-22 Dura Pharmaceuticals, Inc. Dry powder inhaler delivery system
GB2306169B (en) 1995-10-13 2000-01-12 Eastman Kodak Co Zeolite molecular sieves for packaging structures
US5833066A (en) 1996-01-02 1998-11-10 Inhalermate, Llc Carrying case for oral and nasal inhalation devices with counting mechanism
TR199801265T2 (en) 1996-01-03 1998-10-21 Glaxo Group Limited Inhalation device.
US5789044A (en) 1996-01-24 1998-08-04 Eastman Kodak Company Zeolite molecular sieves for packaging structures
US5833093A (en) 1996-03-04 1998-11-10 Honaker; Denise Protective cover for small spray dispensers and medicated inhalers
US5773105A (en) 1996-03-07 1998-06-30 United Catalysts Inc. - Desiccants Absorbent packet
US5749496A (en) 1996-06-19 1998-05-12 Primary Delivery Systems, Inc. Squeeze and rotate to lift captive cap dispenser
US6112888A (en) * 1996-06-28 2000-09-05 W. R. Grace & Co.-Conn. Non-reclosable packages containing desiccant matrix
DE19633495A1 (en) 1996-08-20 1998-02-26 Sanner Friedr Gmbh Co Kg Desiccant seal for container filled with moisture sensitive goods
DE19646048C2 (en) 1996-11-08 2003-05-28 Michael Horstmann Packaging for transdermal therapeutic systems
SE9700944D0 (en) 1997-03-14 1997-03-14 Astra Ab Powder inhaler VI
US5779122A (en) 1997-05-05 1998-07-14 Martinelli; Vincent Asthma medication pouch
US6093480A (en) 1997-05-21 2000-07-25 Tenneco Packaging Stretch wrap films
US6103280A (en) 1997-09-20 2000-08-15 Bass Public Limited Company Self-cooling containers of beverage and foodstuffs
US6617321B2 (en) * 1997-09-30 2003-09-09 Eli Lilly And Company 2-methyl-thieno-benzodiazepine formulation
NZ505349A (en) 1997-12-22 2002-02-01 Astrazeneca Ab A suction tube for use drawing powdered medicament from a blister pack has cutting blade extending across inlet of the suction tube and has a bearing surface in the form of a ram blade
US6039718A (en) 1998-01-20 2000-03-21 Bracco Research Usa Multiple use universal connector
US6019751A (en) 1998-01-20 2000-02-01 Bracco Research Usa Universal connector and a medical container
JPH11206850A (en) * 1998-01-29 1999-08-03 Dai Ichi Seiyaku Co Ltd Drug packaging body
US5896989A (en) 1998-02-20 1999-04-27 Bracco Research Usa Flexible medical container packaging
GB9807232D0 (en) 1998-04-03 1998-06-03 Univ Cardiff Aerosol composition
US6207093B1 (en) 1998-04-24 2001-03-27 Fina Technology, Inc. Compositions for improved orientation processing
US6241132B1 (en) 1998-05-13 2001-06-05 The Testor Corporation Fluid dispensing apparatus with fitment spout and valve
CA2334014A1 (en) * 1998-06-04 1999-12-09 Ihab M. Hekal Desiccant blended in a thermoplastic
US6119853A (en) 1998-12-18 2000-09-19 Glaxo Wellcome Inc. Method and package for storing a pressurized container containing a drug
US6352152B1 (en) 1998-12-18 2002-03-05 Smithkline Beecham Corporation Method and package for storing a pressurized container containing a drug
US6390291B1 (en) * 1998-12-18 2002-05-21 Smithkline Beecham Corporation Method and package for storing a pressurized container containing a drug
US6315112B1 (en) 1998-12-18 2001-11-13 Smithkline Beecham Corporation Method and package for storing a pressurized container containing a drug
US6250468B1 (en) 1999-02-10 2001-06-26 Teepak Investments, Inc. Easy to remove overwrap
US6531197B2 (en) 1999-04-26 2003-03-11 Illinois Tool Works Desiccant barrier container
FR2793379B1 (en) 1999-05-11 2001-07-06 Kuhn Sa Adapter device for tractor drawbar
US6360929B1 (en) 2000-07-17 2002-03-26 Mccarthy Madeleine Medicinal atomizing inhaler pouch/retainer
FR2812620B1 (en) * 2000-08-04 2002-12-27 David Platre Device for reversible closure for container
SE0401654D0 (en) 2004-06-24 2004-06-24 Astrazeneca Ab A support structure for a medicament

Patent Citations (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3333683A (en) * 1966-02-17 1967-08-01 Anaconda Aluminum Co Cigarette package
US3371825A (en) * 1966-05-12 1968-03-05 Multiform Desiccant Products I Sorptive getter for pressure discharge dispensers
US3670874A (en) * 1968-12-05 1972-06-20 Sulzer Ag Method for irradiating foodstuffs and other consumables, pharmaceuticals and the like, and a package for same
US3738540A (en) * 1970-04-01 1973-06-12 Oreal Container for corrosive products to be stored under pressure
US3704806A (en) * 1971-01-06 1972-12-05 Le T Im Lensoveta Dehumidifying composition and a method for preparing the same
US3809223A (en) * 1971-08-27 1974-05-07 Crown Zellerbach Corp Protected lumber package and method of making same
US3788322A (en) * 1972-12-27 1974-01-29 Alza Corp Drug delivery device with means for maintaining device in environment of use
US3797492A (en) * 1972-12-27 1974-03-19 Alza Corp Device for dispensing product with directional guidance member
US4135622A (en) * 1973-03-28 1979-01-23 American Cyanamid Company Packaged, desiccated surgical elements
US4042170A (en) * 1975-05-06 1977-08-16 Ab Svenska Dental Instrument Sterile package
US4305502A (en) * 1977-07-20 1981-12-15 John Wyeth & Brother Limited Pharmaceutical dosage form packges
US4449832A (en) * 1981-03-20 1984-05-22 Dieter Graesslin Feinwerktechnik Program input and/or time setting device
US4447565A (en) * 1981-12-07 1984-05-08 The United States Of America As Represented By The United States Department Of Energy Method and composition for molding low density desiccant syntactic foam articles
US4363841A (en) * 1981-12-28 1982-12-14 Champion International Corporation Laminated packaging material
US5560490A (en) * 1992-09-09 1996-10-01 Fisons Plc Pharmaceutical packaging with capsule sealing means
US6279736B1 (en) * 1995-04-19 2001-08-28 Capitol Specialty Plastics, Inc. Barrier pack having an absorbing agent applied to the interior of the pack
US20030235664A1 (en) * 2002-06-20 2003-12-25 Rick Merical Films having a desiccant material incorporated therein and methods of use and manufacture
US20040131805A1 (en) * 2002-06-20 2004-07-08 Merical Rick L. Films having a desiccant material incorporated therein and methods of use and manufacture
US20060269708A1 (en) * 2002-06-20 2006-11-30 Rick Merical Films having a desiccant material incorporated therein and methods of use and manufacture
US20060134007A1 (en) * 2004-10-21 2006-06-22 Boehringer Ingelheim International Gmbh Blister for inhalers

Cited By (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9801925B2 (en) 1999-06-29 2017-10-31 Mannkind Corporation Potentiation of glucose elimination
US9700690B2 (en) 2002-03-20 2017-07-11 Mannkind Corporation Inhalation apparatus
US9796688B2 (en) 2004-08-20 2017-10-24 Mannkind Corporation Catalysis of diketopiperazine synthesis
US9675674B2 (en) 2004-08-23 2017-06-13 Mannkind Corporation Diketopiperazine salts for drug delivery and related methods
US10130685B2 (en) 2004-08-23 2018-11-20 Mannkind Corporation Diketopiperazine salts for drug delivery and related methods
US20080092887A1 (en) * 2004-12-07 2008-04-24 Hodson Peter D Single-Dose Inhalation Devices
US10143655B2 (en) 2005-09-14 2018-12-04 Mannkind Corporation Method of drug formulation
US9717689B2 (en) 2005-09-14 2017-08-01 Mannkind Corporation Method of drug formulation based on increasing the affinity of crystalline microparticle surfaces for active agents
US9446001B2 (en) 2005-09-14 2016-09-20 Mannkind Corporation Increasing drug affinity for crystalline microparticle surfaces
US9283193B2 (en) 2005-09-14 2016-03-15 Mannkind Corporation Method of drug formulation based on increasing the affinity of crystalline microparticle surfaces for active agents
US10130581B2 (en) 2006-02-22 2018-11-20 Mannkind Corporation Method for improving the pharmaceutic properties of microparticles comprising diketopiperazine and an active agent
US9241903B2 (en) 2006-02-22 2016-01-26 Mannkind Corporation Method for improving the pharmaceutic properties of microparticles comprising diketopiperazine and an active agent
US20110174665A1 (en) * 2007-04-27 2011-07-21 Daiwa Can Company Polyester Resin Container With Fracturable Portion And Its Production Method
US9808077B2 (en) * 2007-08-17 2017-11-07 Noble Innovations Llc Toothbrush system utilizing oral care capsule
US20150083747A1 (en) * 2007-08-17 2015-03-26 Noble Innovations Llc Toothbrush system utilizing oral care capsule
US20110120464A1 (en) * 2008-01-11 2011-05-26 Innovata Biomed Limited Inhalers
US20110203586A1 (en) * 2008-02-20 2011-08-25 Boehringer Ingelheim International Gmbh Powder Inhalers
US20090235929A1 (en) * 2008-03-19 2009-09-24 Marc Egen Powder inhalers
US20130032145A1 (en) * 2008-05-01 2013-02-07 Dan Adler Dry powder inhaler
US9662461B2 (en) 2008-06-13 2017-05-30 Mannkind Corporation Dry powder drug delivery system and methods
US9511198B2 (en) 2008-06-13 2016-12-06 Mannkind Corporation Dry powder inhaler and system for drug delivery
US9192675B2 (en) 2008-06-13 2015-11-24 Mankind Corporation Dry powder inhaler and system for drug delivery
US9446133B2 (en) 2008-06-13 2016-09-20 Mannkind Corporation Dry powder inhaler and system for drug delivery
US9339615B2 (en) 2008-06-13 2016-05-17 Mannkind Corporation Dry powder inhaler and system for drug delivery
US10201672B2 (en) 2008-06-13 2019-02-12 Mannkind Corporation Dry powder inhaler and system for drug delivery
US9364619B2 (en) 2008-06-20 2016-06-14 Mannkind Corporation Interactive apparatus and method for real-time profiling of inhalation efforts
US9943571B2 (en) 2008-08-11 2018-04-17 Mannkind Corporation Use of ultrarapid acting insulin
US9220687B2 (en) 2008-12-29 2015-12-29 Mannkind Corporation Substituted diketopiperazine analogs for use as drug delivery agents
US9655850B2 (en) 2008-12-29 2017-05-23 Mannkind Corporation Substituted diketopiperazine analogs for use as drug delivery agents
US10172850B2 (en) 2008-12-29 2019-01-08 Mannkind Corporation Substituted diketopiperazine analogs for use as drug delivery agents
US9983108B2 (en) 2009-03-11 2018-05-29 Mannkind Corporation Apparatus, system and method for measuring resistance of an inhaler
US9630930B2 (en) 2009-06-12 2017-04-25 Mannkind Corporation Diketopiperazine microparticles with defined specific surface areas
US8679395B2 (en) * 2009-07-14 2014-03-25 Sanofi-Aventis Deutschland Gmbh Medicament container
US20120179094A1 (en) * 2009-07-14 2012-07-12 Sanofi-Aventis Deutschland Gmbh Medicament container
US9706944B2 (en) 2009-11-03 2017-07-18 Mannkind Corporation Apparatus and method for simulating inhalation efforts
US20130153459A1 (en) * 2010-09-01 2013-06-20 Kyodo Printing Co., Ltd. Package
US8925726B2 (en) * 2011-04-01 2015-01-06 Mannkind Corporation Blister package for pharmaceutical cartridges
US20120248005A1 (en) * 2011-04-01 2012-10-04 Mannkind Corporation Blister Package for Pharmaceutical Cartridges
AU2012236150B2 (en) * 2011-04-01 2016-03-31 Mannkind Corporation Blister package for pharmaceutical cartridges
US9364436B2 (en) 2011-06-17 2016-06-14 Mannkind Corporation High capacity diketopiperazine microparticles and methods
US10130709B2 (en) 2011-06-17 2018-11-20 Mannkind Corporation High capacity diketopiperazine microparticles and methods
US10258664B2 (en) 2011-10-24 2019-04-16 Mannkind Corporation Methods and compositions for treating pain
US9233159B2 (en) 2011-10-24 2016-01-12 Mannkind Corporation Methods and compositions for treating pain
US9610351B2 (en) 2011-10-24 2017-04-04 Mannkind Corporation Methods and compositions for treating pain
US9802012B2 (en) 2012-07-12 2017-10-31 Mannkind Corporation Dry powder drug delivery system and methods
US10159644B2 (en) 2012-10-26 2018-12-25 Mannkind Corporation Inhalable vaccine compositions and methods
US9925144B2 (en) 2013-07-18 2018-03-27 Mannkind Corporation Heat-stable dry powder pharmaceutical compositions and methods

Also Published As

Publication number Publication date
DE60126609D1 (en) 2007-03-29
AU7408601A (en) 2002-01-02
BR0111252A (en) 2003-06-03
EP1760008A1 (en) 2007-03-07
ZA200208212B (en) 2003-07-17
WO2001098174A1 (en) 2001-12-27
CA2411109A1 (en) 2001-12-27
US20030140923A1 (en) 2003-07-31
AT353834T (en) 2007-03-15
EP1292510B1 (en) 2007-02-14
EP1292510A1 (en) 2003-03-19
CN1437551A (en) 2003-08-20
MXPA02012680A (en) 2003-04-25
DE60126609T2 (en) 2007-10-31
EP1292510B2 (en) 2011-07-20
US7828150B2 (en) 2010-11-09
GB0015043D0 (en) 2000-08-09
ES2282261T3 (en) 2007-10-16
DE60126609T3 (en) 2012-01-26
JP2003535782A (en) 2003-12-02

Similar Documents

Publication Publication Date Title
AU763266B2 (en) Two-piece capsule for receiving pharmaceutical preparations for powder inhalers
US7322353B2 (en) Breath actuated dry powder inhaler and tape dose strip
US7383837B2 (en) Inhalation device
CN1145005C (en) Product containing shaped product
CA2322434C (en) Medicament delivery and packaging
US6536427B2 (en) Inhalation device
CA2404225C (en) Medicament container with same side airflow inlet and outlet and method of use
CN1196631C (en) Product containing shaped product or shaped whole composition
FI79651C (en) Doseringsanordning Foer medicin.
US5114003A (en) Tablet vial with desiccant in bottom
US6941947B2 (en) Unit dose dry powder inhaler
US20060102511A1 (en) Blister package for inhalable medicament
EP0567529B2 (en) Oxygen-absorbing label
US6098619A (en) Unit dose inhaler apparatus and method of delivery using same
US20070062525A1 (en) Medicament dispenser
KR101214823B1 (en) Inhaler for the administration of powdered pharmaceuticals, and a powder cartridge system for use with this inhaler
US9339616B2 (en) Dry powder inhalers
AU2007210177C1 (en) Dry powder inhalers having spiral travel paths, unit dose microcartridges with dry powder, related devices and methods
US6871647B2 (en) Inhaler
DK1786498T3 (en) Medicament dispenser.
US8763605B2 (en) Inhalation device
ES2366683T3 (en) sealed cartridge for a dry powder inhaler.
AU2012236150B2 (en) Blister package for pharmaceutical cartridges
US20090308388A1 (en) Inhaler
US6679254B1 (en) Inhalation device